Zolgensma tumor cases show risks of a common gene therapy tool
New cases show AAV gene therapies like Zolgensma carry tumor risks, raising key concerns for SMA patients and gene therapy researchers in general.
The report was published on 06 de novembro de 2026 às 13:40 by STAT and is part of the World news coverage.
What other outlets are saying
- Endpoints News: Seven new tumor cases reported among patients on Novartis’ Zolgensma gene therapy
- BioSpace: Novartis confirms 9 reported cases of tumors in patients treated with Zolgensma
- STAT: Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy
- BioSpace: Novartis confirms 9 reported cases of tumors in patients treated with Zolgensma
Quick answers
Who reported this story?
It was first reported by STAT on 06 de novembro de 2026 às 13:40.
What is the category?
It is filed under World news on Rio Warzone News.
